Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-22-2026-05_46_48-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Regulatory
  • FDA taps prior knowledge to expedite cell and gene therapy development
  • Regulatory

FDA taps prior knowledge to expedite cell and gene therapy development

BioSpace

A year of significant policy change at the FDA brought momentum and scrutiny into the new year.

Gene Therapy Platform

Read full story

pharminent June 3, 2026 (Last updated: June 3, 2026)

BioSpace

A year of significant policy change at the FDA brought momentum and scrutiny into the new year.

Gene Therapy Platform

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: AbbVie receives EC approval for Aquipta to treat migraine
Next: Travere beefs up rare kidney disease portfolio with up to $1.1B China deal

Related Stories

  • Regulatory

Replimune gets early August decision date for twice-rejected melanoma drug

pharminent June 26, 2026
  • Regulatory

Ionis secures market expansion for Tryngolza as FDA clears severe hypertriglyceridemia use

pharminent June 25, 2026
  • Regulatory

MSD’s Keytruda-Padcev combo secures EC approval for MIBC

pharminent June 25, 2026

You May Have Missed

  • News

Lilly Medicare GLP-1 Bridge Launches July 1 With Foundayo and Zepbound

pharminent June 26, 2026
  • News

Moderna Maps R&D ‘Horizons’ as 2028 Break-Even Goal Looms

pharminent June 26, 2026
  • Regulatory

Replimune gets early August decision date for twice-rejected melanoma drug

pharminent June 26, 2026
  • Pipeline

Moderna looks out to R&D ‘horizons’ as 2028 break-even goal looms

pharminent June 26, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.